glp-1 sleep apnea trial GLP1 Drugs Help Protect Against Study Says Sleep Apnea May Amplify GLP-1

We believe in systems, not guesswork

Jun 2015;31(3):166-172.

By targeting the gut, pancreas, and brain simultaneously, they reduce cravings, stabilize metabolism, and create sustainable results

In the larger SELECT trial in 2023, patients with heart failure, atherosclerotic disease, and overweight or obesity, treated with semaglutide 2.4 mg showed reduction in major adverse cardiac events (MACE) and heart failure end points regardless of heart failure subgroup being HFrEF or HFpEF [56,57,58]

& Fuchs, E

Your body may convert your T4 medication into inactive reverse T3 instead of active T3, especially if you have inflammation, insulin resistance, leptin resistance, or nutrient deficiencies